Search

everythinglearnresearchcommunity

for

Search:↓

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

TMPRSS2 helps viruses enter cells and protects the prostate from inflammation-related cancer.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Early lung cancer screening in Ontario reduces deaths and is cost-effective.

Hair loss may indicate higher heart risk and metabolic issues.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Cosmetics can contain harmful chemicals that may cause health issues.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Finasteride doesn't raise acute pancreatitis risk.